Afya Stock Price To Earning
| AFYA Stock | USD 14.81 0.01 0.07% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Afya's long-term financial health and intrinsic value.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Afya Company Price To Earning Analysis
Afya's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Afya Price To Earning | 33.33 X |
Most of Afya's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Afya is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, Afya has a Price To Earning of 33.33 times. This is 58.94% higher than that of the Diversified Consumer Services sector and 61.87% higher than that of the Consumer Discretionary industry. The price to earning for all United States stocks is 16.05% lower than that of the firm.
Afya Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Afya's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Afya could also be used in its relative valuation, which is a method of valuing Afya by comparing valuation metrics of similar companies.Afya is currently under evaluation in price to earning category among its peers.
Afya Fundamentals
| Return On Equity | 0.17 | |||
| Return On Asset | 0.0835 | |||
| Profit Margin | 0.20 % | |||
| Operating Margin | 0.30 % | |||
| Current Valuation | 1.77 B | |||
| Shares Outstanding | 46.89 M | |||
| Shares Owned By Insiders | 68.10 % | |||
| Shares Owned By Institutions | 19.90 % | |||
| Number Of Shares Shorted | 272.98 K | |||
| Price To Earning | 33.33 X | |||
| Price To Book | 1.60 X | |||
| Price To Sales | 0.37 X | |||
| Revenue | 3.3 B | |||
| Gross Profit | 2.36 B | |||
| EBITDA | 1.22 B | |||
| Net Income | 676.39 M | |||
| Cash And Equivalents | 616.25 M | |||
| Cash Per Share | 6.85 X | |||
| Total Debt | 3.17 B | |||
| Debt To Equity | 0.71 % | |||
| Current Ratio | 1.33 X | |||
| Book Value Per Share | 9.74 X | |||
| Cash Flow From Operations | 1.43 B | |||
| Short Ratio | 3.27 X | |||
| Earnings Per Share | 1.49 X | |||
| Price To Earnings To Growth | 12.26 X | |||
| Target Price | 18.39 | |||
| Beta | 0.54 | |||
| Market Capitalization | 1.34 B | |||
| Total Asset | 8.83 B | |||
| Retained Earnings | 2.01 B | |||
| Working Capital | 449.59 M | |||
| Current Asset | 1.2 B | |||
| Current Liabilities | 284.9 M | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 8.83 B | |||
| Last Dividend Paid | 1.35 |
About Afya Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Afya's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Afya using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Afya based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Afya offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Afya's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Afya Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Afya Stock:Check out Afya Piotroski F Score and Afya Altman Z Score analysis. For information on how to trade Afya Stock refer to our How to Trade Afya Stock guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Stock space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Afya. If investors know Afya will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Afya listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Afya is measured differently than its book value, which is the value of Afya that is recorded on the company's balance sheet. Investors also form their own opinion of Afya's value that differs from its market value or its book value, called intrinsic value, which is Afya's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Afya's market value can be influenced by many factors that don't directly affect Afya's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Afya's value and its price as these two are different measures arrived at by different means. Investors typically determine if Afya is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Afya's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.